Radiofrequency Ablation for Papillary Microcarcinoma of the Thyroid

Yang, Shangbin; Xu, Xiequn

doi:10.1001/jamaoto.2022.1174

Cited by 3 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…RFA can be used as an effective and safe method for the treatment of PTMC close to thyroid capsule and PTMC far from thyroid capsule, as shown in our study. RFA is a minimally invasive alternative with promising outcomes and preservation of thyroid parenchyma, which that reduces the need for post-treatment replacement thyroid hormone, as reported [16][17][18].…”

Section: Discussionmentioning

confidence: 93%

Radiofrequency ablation for papillary thyroid microcarcinoma close to the thyroid capsule versus far from the thyroid capsule: a retrospective study

Luo,

Hui,

Jin

et al. 2024

Endokrynol Pol

View full text Add to dashboard Cite

The most frequently used methods for PTMC TA are radiofrequency ablation (RFA), microwave ablation (MWA), and laser ablation (LA) [8][9][10][11]. TA has the advantage of avoiding incisions, taking shorter operative time and reducing the length of stay of inpatients compared with thyroidectomy [12][13][14]. RFA introduces electrodes into the lesion area, which use an alternating current to generate local thermal energy with a frequency ranging between 200 and 1200 kHz, resulting in tissue necrosis and tissue degeneration due to a high local temperature [15]. RFA is terminated when the area of the nodule becomes hyperechoic on ultrasound or when the impedance increases, or a combination of the two [15]. The 2017 Korean RFA guidelines present the potential therapeutic role of RFA in PTMC patients who refuse or are ineligible for surgery [3].RFA has been shown to be an effective treatment method for PTMC far from the thyroid capsule.

show abstract

Section: Discussionmentioning

confidence: 93%

Radiofrequency ablation for papillary thyroid microcarcinoma close to the thyroid capsule versus far from the thyroid capsule: a retrospective study

Luo,

Hui,

Jin

et al. 2024

Endokrynol Pol

View full text Add to dashboard Cite

show abstract

“…RFA has been rapidly promoted as the first approach for treating benign thyroid tumors or even for the palliative treatment of metastatic lymph nodes in patients with thyroid cancer because it is minimally invasive and has no impact on aesthetic appearance ( 27 ). Multiple studies have reported that using RFA for patients with PTMC was safe, effective, and reliable ( 28 , 29 ). Our study confirmed the safety, efficacy, and reliability of RFA in treating T1N0M0 PTC.…”

Section: Discussionmentioning

confidence: 99%

Efficacy, safety, and controversy of ultrasound-guided radiofrequency ablation in the treatment of T1N0M0 papillary thyroid carcinoma

Zhang

et al. 2022

Front. Oncol.

View full text Add to dashboard Cite

ObjectiveTo evaluate the safety effect, and controversy on the treatment outcomes of radiofrequency ablation (RFA) for T1N0M0 papillary thyroid carcinoma (PTC).Materials and methodsThis study is assessed the medical records of 142 patients with primary T1N0M0 PTC tumors after RFA between 2014 and 2022. 4 patients underwent delayed surgery (DS) after RFA and 411 T1N0M0 patients underwent DS were recorded. Outcomes were compared between RFA and DS groups after propensity score matching (PSM).ResultsThe maximal diameter (MD) and volume (V) increased in months 1 (P < 0.01) and reduced after the 6-month follow-up (all P < 0.01). The disappearance and disease progression rates were 53.5% and 2.1%, respectively. The complication and disease progression rates had no significant difference between RFA and DS (P>0.05). In some cases, the tumors were not fully inactivated after RFA, and the central compartment lymph node (CCLN) were metastasis. The CCLN metastasis rate was 13.4%. MD, V and clustered calcifications were independent risk factors for CCLN metastasis by univariate analysis.ConclusionsRFA is an effective and safe treatment option in selected patients with solitary T1N0M0 PTC. There are the risks of tumor incompletely ablated and CCLN metastasis.

show abstract

“…RFA is not recommended for treating these aggressive subtypes. The combined analysis of molecular markers—such as the BRAF , RAS , TERT promoter, RET , and TP53 genes, along with the fusion genes RET / PTC , PAX8/PPARG , and NTRK [ 61 - 63 ]—in conjunction with the application of artificial intelligence [ 64 ] may facilitate the accurate evaluation of the aggressiveness, prognostic implications, and recurrence risk of PTC.…”

Section: Future Directionsmentioning

confidence: 99%

Ultrasound-guided radiofrequency ablation for the treatment of papillary thyroid carcinoma: a review of the current state and future perspectives

Zhao,

Zhang

2024

Ultrasonography

View full text Add to dashboard Cite

Papillary thyroid carcinoma (PTC) is a highly prevalent cancer that typically exhibits indolent behavior and is associated with a favorable prognosis. The treatment of choice is surgical intervention; however, this approach carries the risk of complications, including scarring and loss of thyroid function. Although active surveillance can mitigate the risk of PTC overtreatment, the possibility of tumor growth and metastasis can elicit anxiety among patients. Ultrasoundguided thermal ablation has emerged as a safe and effective alternative for individuals who are ineligible for or decline surgery. This article provides a review of the clinical research on radiofrequency ablation as a treatment for PTC, offering a thorough examination of its efficacy, safety, and future perspectives.

show abstract

Radiofrequency Ablation for Papillary Microcarcinoma of the Thyroid

Abstract: y 4. Carneiro-Pla DM, Solorzano CC, Irvin GL III. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring.

Cited by 3 publications

References 6 publications

Radiofrequency ablation for papillary thyroid microcarcinoma close to the thyroid capsule versus far from the thyroid capsule: a retrospective study

Radiofrequency ablation for papillary thyroid microcarcinoma close to the thyroid capsule versus far from the thyroid capsule: a retrospective study

Efficacy, safety, and controversy of ultrasound-guided radiofrequency ablation in the treatment of T1N0M0 papillary thyroid carcinoma

Ultrasound-guided radiofrequency ablation for the treatment of papillary thyroid carcinoma: a review of the current state and future perspectives

Contact Info

Product

Resources

About